Literature DB >> 1947093

Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress.

W B Pierce1, S E Harms, D P Flamig, R H Griffey, W P Evans, J E Hagans.   

Abstract

A pulse sequence with magnetization transfer contrast and fat suppression was used in three-dimensional magnetic resonance imaging of the breast. Two healthy volunteers, one person with silicone implants, and 12 patients with clinical and/or mammographic findings suspicious for malignancy were evaluated prior to and following infusion of gadopentetate dimeglumine. Imaging time was approximately 7 minutes for each set of data (128 sections). Final voxel dimensions ranged from 1.4 x 0.8 x 0.8 mm to 1.6 x 0.9 x 0.9 mm. All carcinomas, including ductal and lobular types, were enhanced before and after infusion of contrast medium. Multifocal carcinoma and inflammatory carcinoma could be clearly visualized. Enhancement was not evident in patients with fat necrosis (n = 1) or scar (n = 1). Fibrocystic changes in one patient were visible as areas of increased signal intensity on preinfusion images. Resolution and contrast of MR images obtained with this pulse sequence appeared to be improved over that achieved with conventional breast MR imaging techniques. This method has the potential to supplement conventional diagnostic methods in the evaluation of breast disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1947093     DOI: 10.1148/radiology.181.3.1947093

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

Review 1.  Integration of breast imaging into cancer management.

Authors:  L J Esserman; D Wolverton; N Hylton
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

2.  History of the Baylor Charles A. Sammons Cancer Center.

Authors:  Marvin J Stone; Billie E Aronoff; W Phil Evans; Joseph W Fay; Z H Lieberman; Carolyn M Matthews; George J Race; R Pickett Scruggs; C Allen Stringer
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-01

3.  Dynamics of paramagnetic agents by off-resonance rotating frame technique in the presence of magnetization transfer effect.

Authors:  Huiming Zhang; Yang Xie
Journal:  J Magn Reson       Date:  2006-11-22       Impact factor: 2.229

Review 4.  Magnetization transfer imaging of multiple sclerosis.

Authors:  G B Pike
Journal:  Ital J Neurol Sci       Date:  1997-12

5.  Ultrasonography alone for diagnosis of breast cancer in women under 40.

Authors:  D C Appleton; L Hackney; S Narayanan
Journal:  Ann R Coll Surg Engl       Date:  2014-04       Impact factor: 1.891

6.  Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography.

Authors:  P L Davis; M J Staiger; K B Harris; M A Ganott; J Klementaviciene; K S McCarty; H Tobon
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Pathological assessment of the response of locally advanced breast cancer to neoadjuvant chemotherapy and its implications for surgical management.

Authors:  M H El-Didi; M M Moneer; H M Khaled; S Makarem
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

8.  New modalities in breast imaging: digital mammography and magnetic resonance imaging.

Authors:  M P Braeuning; E D Pisano
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

9.  Dynamic contrast-enhanced MR imaging of the entire breast with spectral-selective inversion fast three dimensional sequence.

Authors:  M Goto; H Sakuma; S Kobayashi; K Matsumura; K Takeda
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

Review 10.  25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives.

Authors:  Jessica Lohrke; Thomas Frenzel; Jan Endrikat; Filipe Caseiro Alves; Thomas M Grist; Meng Law; Jeong Min Lee; Tim Leiner; Kun-Cheng Li; Konstantin Nikolaou; Martin R Prince; Hans H Schild; Jeffrey C Weinreb; Kohki Yoshikawa; Hubertus Pietsch
Journal:  Adv Ther       Date:  2016-01-25       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.